| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.3748/WJG.V23.I17.3022 |
| P8608 | Fatcat ID | release_pebprwp2bremnkz6tf3ipdc24y |
| P932 | PMC publication ID | 5423039 |
| P698 | PubMed publication ID | 28533659 |
| P2093 | author name string | Fergal C Kelleher | |
| Catriona Gallagher | |||
| Hazel O'Sullivan | |||
| Grainne Callaghan | |||
| P2860 | cites work | Progression of RAS-mutant leukemia during RAF inhibitor treatment | Q39873892 |
| MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells | Q39927766 | ||
| Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. | Q40583206 | ||
| BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer | Q41056167 | ||
| Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors | Q42454422 | ||
| BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. | Q44564090 | ||
| New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma | Q53066271 | ||
| Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer | Q53260087 | ||
| Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis | Q53306400 | ||
| Progressive methylation during the serrated neoplasia pathway of the colorectum | Q53633996 | ||
| Oncosuppressor methylation: A possible key role in colon metastatic progression | Q60170548 | ||
| BRAFMutation in Metastatic Colorectal Cancer | Q61481269 | ||
| Molecular Genetics of Colorectal Cancer | Q82521439 | ||
| Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma | Q84416136 | ||
| Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF | Q24298749 | ||
| The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells | Q24680814 | ||
| Serrated lesions of the colorectum: review and recommendations from an expert panel | Q26827208 | ||
| RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth | Q27659493 | ||
| A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. | Q27852431 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells | Q28219173 | ||
| The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype | Q28247866 | ||
| The serial cultivation of human diploid cell strains | Q29547356 | ||
| RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF | Q29616828 | ||
| The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus | Q29619815 | ||
| Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample | Q33383866 | ||
| Three DNA methylation epigenotypes in human colorectal cancer | Q33520394 | ||
| BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome | Q33906044 | ||
| Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis | Q34169734 | ||
| Colorectal serrated adenocarcinoma | Q34597935 | ||
| Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors | Q36342842 | ||
| The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis | Q36510909 | ||
| Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | Q36699559 | ||
| BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. | Q37056074 | ||
| Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas | Q37274510 | ||
| Toward a comprehensive and systematic methylome signature in colorectal cancers | Q37445275 | ||
| Serrated polyps and colorectal cancer: new pathway to malignancy | Q37463062 | ||
| Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes | Q37821085 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3022-3029 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis | |
| P478 | volume | 23 |
| Q64974016 | Malignant Melanoma Metastasizes to Colonic Polyp. | cites work | P2860 |
Search more.